{"transactions":[{"id":4624585,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-22T20:12:00.000Z","date":"2026-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":2555,"price":4.01,"value":10245.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 21, 2026."}],"balance_after":287193,"source":{"system":"sec-edgar","filing":"0002082246-26-000010","document":"wk-form4_1790107917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2082246/000208224626000010/wk-form4_1790107917.xml","form_type":"4"}},{"id":4621449,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":93834,"kind":"person","name":"Sikri Vishal","position":1,"cik":"0001931406","reported_name":"Sikri Vishal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial"}}],"security":"Common Stock","published_at":"2026-09-17T20:34:28.000Z","date":"2026-09-16","kind":"grant","planned":false,"acquired":true,"shares":257731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":351224,"source":{"system":"sec-edgar","filing":"0001931406-26-000007","document":"wk-form4_1789677266.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1931406/000193140626000007/wk-form4_1789677266.xml","form_type":"4"}},{"id":3519810,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:18:50.000Z","date":"2026-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4398,"price":3.23,"value":14205.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 3, 2026."}],"balance_after":305964,"source":{"system":"sec-edgar","filing":"0001914879-26-000004","document":"wk-form4_1788898728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914879/000191487926000004/wk-form4_1788898728.xml","form_type":"4"}},{"id":686117,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-17T20:26:00.000Z","date":"2026-08-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":8761,"price":3.03,"value":26545.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on August 14, 2026."}],"balance_after":289748,"source":{"system":"sec-edgar","filing":"0002082246-26-000008","document":"wk-form4_1786998358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224626000008/wk-form4_1786998358.xml","form_type":"4"}},{"id":740720,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39036,"kind":"person","name":"Raha Samraat S.","position":1,"cik":"0001738340","reported_name":"Raha Samraat S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-12T22:06:04.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":3542,"price":3.936,"value":13941.312,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":1068083,"source":{"system":"sec-edgar","filing":"0001738340-26-000006","document":"wk-form4_1781301961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000173834026000006/wk-form4_1781301961.xml","form_type":"4"}},{"id":740719,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2026-06-12T22:05:58.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":3.936,"value":19680.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":573363,"source":{"system":"sec-edgar","filing":"0002065630-26-000006","document":"wk-form4_1781301956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563026000006/wk-form4_1781301956.xml","form_type":"4"}},{"id":745389,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":40258,"kind":"person","name":"Kumar Rashmi","position":1,"cik":"0001824720","reported_name":"Kumar Rashmi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T20:20:47.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":4.4562,"value":66843.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.37 to $4.63, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":171889,"source":{"system":"sec-edgar","filing":"0001824720-26-000004","document":"wk-form4_1781036444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000182472026000004/wk-form4_1781036444.xml","form_type":"4"}},{"id":748735,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":11095,"kind":"person","name":"Skovronsky Daniel","position":1,"cik":"0001741474","reported_name":"Skovronsky Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:25:50.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":195507,"source":{"system":"sec-edgar","filing":"0001628280-26-041258","document":"wk-form4_1780691148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828026041258/wk-form4_1780691148.xml","form_type":"4"}},{"id":748734,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:25:25.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":191842,"source":{"system":"sec-edgar","filing":"0001788981-26-000002","document":"wk-form4_1780691122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000178898126000002/wk-form4_1780691122.xml","form_type":"4"}},{"id":748733,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38551,"kind":"person","name":"Davis Mark Steven","position":1,"cik":"0002024613","reported_name":"Davis Mark Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:25:19.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":106665,"source":{"system":"sec-edgar","filing":"0002024613-26-000002","document":"wk-form4_1780691117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000202461326000002/wk-form4_1780691117.xml","form_type":"4"}},{"id":748732,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":22863,"kind":"person","name":"Phanstiel S. Louise","position":1,"cik":"0001471518","reported_name":"Phanstiel S. Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:25:12.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":341652,"source":{"system":"sec-edgar","filing":"0001471518-26-000004","document":"wk-form4_1780691109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000147151826000004/wk-form4_1780691109.xml","form_type":"4"}},{"id":748731,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41113,"kind":"person","name":"Dreismann Heinrich","position":1,"cik":"0001379372","reported_name":"Dreismann Heinrich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:25:05.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":231145,"source":{"system":"sec-edgar","filing":"0001379372-26-000002","document":"wk-form4_1780691103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000137937226000002/wk-form4_1780691103.xml","form_type":"4"}},{"id":748730,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:25:00.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":152030,"source":{"system":"sec-edgar","filing":"0001740730-26-000002","document":"wk-form4_1780691097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000174073026000002/wk-form4_1780691097.xml","form_type":"4"}},{"id":748729,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:24:55.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":157142,"source":{"system":"sec-edgar","filing":"0001237253-26-000004","document":"wk-form4_1780691093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000123725326000004/wk-form4_1780691093.xml","form_type":"4"}},{"id":748728,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":40258,"kind":"person","name":"Kumar Rashmi","position":1,"cik":"0001824720","reported_name":"Kumar Rashmi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:24:50.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":186889,"source":{"system":"sec-edgar","filing":"0001824720-26-000002","document":"wk-form4_1780691088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000182472026000002/wk-form4_1780691088.xml","form_type":"4"}},{"id":755960,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":42591,"kind":"person","name":"Jampa Raj","position":1,"cik":"0002134322","reported_name":"Jampa Raj","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-06-02T20:20:57.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":251889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":251889,"source":{"system":"sec-edgar","filing":"0002134322-26-000004","document":"wk-form4_1780431653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000213432226000004/wk-form4_1780431653.xml","form_type":"4"}},{"id":779869,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T21:16:45.000Z","date":"2026-05-14","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":3.685,"value":27637.5,"ownership":{"direct":true},"balance_after":97441,"source":{"system":"sec-edgar","filing":"0001237253-26-000002","document":"wk-form4_1778793403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000123725326000002/wk-form4_1778793403.xml","form_type":"4"}},{"id":794507,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2026-05-04T20:35:41.000Z","date":"2026-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":55975,"price":4.8,"value":268680.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on May 1, 2026."}],"balance_after":568363,"source":{"system":"sec-edgar","filing":"0002065630-26-000004","document":"wk-form4_1777926939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563026000004/wk-form4_1777926939.xml","form_type":"4"}},{"id":808429,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-15T20:20:42.000Z","date":"2026-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1069,"price":4.91,"value":5248.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on April 14, 2026."}],"balance_after":629646,"source":{"system":"sec-edgar","filing":"0001517026-26-000008","document":"wk-form4_1776284439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000008/wk-form4_1776284439.xml","form_type":"4"}},{"id":808428,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-04-15T20:20:14.000Z","date":"2026-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":946,"price":4.91,"value":4644.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on April 14, 2026."}],"balance_after":326310,"source":{"system":"sec-edgar","filing":"0001922964-26-000010","document":"wk-form4_1776284411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000010/wk-form4_1776284411.xml","form_type":"4"}},{"id":831493,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-23T20:23:03.000Z","date":"2026-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2019,"price":4.58,"value":9247.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 20, 2026."}],"balance_after":327256,"source":{"system":"sec-edgar","filing":"0001922964-26-000008","document":"wk-form4_1774297381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000008/wk-form4_1774297381.xml","form_type":"4"}},{"id":831492,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-23T20:22:58.000Z","date":"2026-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2055,"price":4.58,"value":9411.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 20, 2026."}],"balance_after":630715,"source":{"system":"sec-edgar","filing":"0001517026-26-000006","document":"wk-form4_1774297376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000006/wk-form4_1774297376.xml","form_type":"4"}},{"id":831491,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-23T20:22:53.000Z","date":"2026-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":549,"price":4.58,"value":2514.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 20, 2026."}],"balance_after":298509,"source":{"system":"sec-edgar","filing":"0002082246-26-000006","document":"wk-form4_1774297370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224626000006/wk-form4_1774297370.xml","form_type":"4"}},{"id":842675,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:58:00.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8382,"price":4.66,"value":39060.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026."}],"balance_after":180022,"source":{"system":"sec-edgar","filing":"0001843872-26-000005","document":"wk-form4_1773698278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000005/wk-form4_1773698278.xml","form_type":"4"}},{"id":842674,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:58:00.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3355,"price":4.66,"value":15634.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":188404,"source":{"system":"sec-edgar","filing":"0001843872-26-000005","document":"wk-form4_1773698278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000005/wk-form4_1773698278.xml","form_type":"4"}},{"id":842673,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:58:00.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4161,"price":4.66,"value":19390.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":191759,"source":{"system":"sec-edgar","filing":"0001843872-26-000005","document":"wk-form4_1773698278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000005/wk-form4_1773698278.xml","form_type":"4"}},{"id":842672,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:58:00.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":6412,"price":4.66,"value":29879.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":195920,"source":{"system":"sec-edgar","filing":"0001843872-26-000005","document":"wk-form4_1773698278.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000005/wk-form4_1773698278.xml","form_type":"4"}},{"id":842671,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60830,"kind":"person","name":"Solaiman Shereen","position":1,"cik":"0001472827","reported_name":"Solaiman Shereen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:09.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":5784,"price":4.66,"value":26953.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":267801,"source":{"system":"sec-edgar","filing":"0001472827-26-000004","document":"wk-form4_1773695166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000147282726000004/wk-form4_1773695166.xml","form_type":"4"}},{"id":842670,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60830,"kind":"person","name":"Solaiman Shereen","position":1,"cik":"0001472827","reported_name":"Solaiman Shereen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:09.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":8899,"price":4.66,"value":41469.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":273585,"source":{"system":"sec-edgar","filing":"0001472827-26-000004","document":"wk-form4_1773695166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000147282726000004/wk-form4_1773695166.xml","form_type":"4"}},{"id":842669,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60830,"kind":"person","name":"Solaiman Shereen","position":1,"cik":"0001472827","reported_name":"Solaiman Shereen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:09.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":173196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":282484,"source":{"system":"sec-edgar","filing":"0001472827-26-000004","document":"wk-form4_1773695166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000147282726000004/wk-form4_1773695166.xml","form_type":"4"}},{"id":842668,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11949,"price":4.66,"value":55682.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026."}],"balance_after":329275,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":842667,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4783,"price":4.66,"value":22288.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":341224,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":842666,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":8288,"price":4.66,"value":38622.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":346007,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":842665,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":12779,"price":4.66,"value":59550.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":354295,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":842664,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":173196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":367074,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":842663,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:54.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":5995,"price":4.66,"value":27936.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":310362,"source":{"system":"sec-edgar","filing":"0001914879-26-000002","document":"wk-form4_1773695152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000191487926000002/wk-form4_1773695152.xml","form_type":"4"}},{"id":842662,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:54.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":195876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":316357,"source":{"system":"sec-edgar","filing":"0001914879-26-000002","document":"wk-form4_1773695152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000191487926000002/wk-form4_1773695152.xml","form_type":"4"}},{"id":842661,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:46.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":226804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":624338,"source":{"system":"sec-edgar","filing":"0002065630-26-000002","document":"wk-form4_1773695144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563026000002/wk-form4_1773695144.xml","form_type":"4"}},{"id":842660,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9096,"price":4.66,"value":42387.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026."}],"balance_after":632770,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":842659,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5611,"price":4.66,"value":26147.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":641866,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":842658,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":5418,"price":4.66,"value":25247.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":647477,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":842657,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":9164,"price":4.66,"value":42704.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":652895,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":842656,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":247423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":662059,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":842655,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:32.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2192,"price":4.66,"value":10214.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026."}],"balance_after":299058,"source":{"system":"sec-edgar","filing":"0002082246-26-000004","document":"wk-form4_1773695129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224626000004/wk-form4_1773695129.xml","form_type":"4"}},{"id":842654,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:32.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":877,"price":4.66,"value":4086.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":301250,"source":{"system":"sec-edgar","filing":"0002082246-26-000004","document":"wk-form4_1773695129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224626000004/wk-form4_1773695129.xml","form_type":"4"}},{"id":842653,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:32.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1097,"price":4.66,"value":5112.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":302127,"source":{"system":"sec-edgar","filing":"0002082246-26-000004","document":"wk-form4_1773695129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224626000004/wk-form4_1773695129.xml","form_type":"4"}},{"id":842652,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:32.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":586,"price":4.66,"value":2730.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":303224,"source":{"system":"sec-edgar","filing":"0002082246-26-000004","document":"wk-form4_1773695129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224626000004/wk-form4_1773695129.xml","form_type":"4"}},{"id":842651,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:32.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":206186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":303810,"source":{"system":"sec-edgar","filing":"0002082246-26-000004","document":"wk-form4_1773695129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224626000004/wk-form4_1773695129.xml","form_type":"4"}},{"id":842650,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39036,"kind":"person","name":"Raha Samraat S.","position":1,"cik":"0001738340","reported_name":"Raha Samraat S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:26.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":10816,"price":4.66,"value":50402.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":1064541,"source":{"system":"sec-edgar","filing":"0001738340-26-000004","document":"wk-form4_1773695121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000173834026000004/wk-form4_1773695121.xml","form_type":"4"}},{"id":842649,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39036,"kind":"person","name":"Raha Samraat S.","position":1,"cik":"0001738340","reported_name":"Raha Samraat S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:26.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":36304,"price":4.66,"value":169176.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":1075357,"source":{"system":"sec-edgar","filing":"0001738340-26-000004","document":"wk-form4_1773695121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000173834026000004/wk-form4_1773695121.xml","form_type":"4"}},{"id":842648,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39036,"kind":"person","name":"Raha Samraat S.","position":1,"cik":"0001738340","reported_name":"Raha Samraat S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:26.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":618557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1111661,"source":{"system":"sec-edgar","filing":"0001738340-26-000004","document":"wk-form4_1773695121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000173834026000004/wk-form4_1773695121.xml","form_type":"4"}},{"id":854723,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39036,"kind":"person","name":"Raha Samraat S.","position":1,"cik":"0001738340","reported_name":"Raha Samraat S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-09T23:03:13.000Z","date":"2026-03-09","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":4.9961,"value":199844.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.97 to $5.00, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":493104,"source":{"system":"sec-edgar","filing":"0001738340-26-000002","document":"wk-form4_1773097390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000173834026000002/wk-form4_1773097390.xml","form_type":"4"}},{"id":875485,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60830,"kind":"person","name":"Solaiman Shereen","position":1,"cik":"0001472827","reported_name":"Solaiman Shereen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:18:28.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1675,"price":4.61,"value":7721.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on February 27, 2026."}],"balance_after":109288,"source":{"system":"sec-edgar","filing":"0001472827-26-000002","document":"wk-form4_1772486306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000147282726000002/wk-form4_1772486306.xml","form_type":"4"}},{"id":878423,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":22863,"kind":"person","name":"Phanstiel S. Louise","position":1,"cik":"0001471518","reported_name":"Phanstiel S. Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T21:46:18.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":48000,"price":4.661,"value":223728.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.79, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":281951,"source":{"system":"sec-edgar","filing":"0001471518-26-000002","document":"wk-form4_1772228775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000147151826000002/wk-form4_1772228775.xml","form_type":"4"}},{"id":878422,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":22863,"kind":"person","name":"Phanstiel S. Louise","position":1,"cik":"0001471518","reported_name":"Phanstiel S. Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T21:46:18.000Z","date":"2026-02-26","kind":"purchase","planned":false,"acquired":true,"shares":50407,"price":4.803,"value":242104.821,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.71 to $5.01, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":233951,"source":{"system":"sec-edgar","filing":"0001471518-26-000002","document":"wk-form4_1772228775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000147151826000002/wk-form4_1772228775.xml","form_type":"4"}},{"id":878421,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":22863,"kind":"person","name":"Phanstiel S. Louise","position":1,"cik":"0001471518","reported_name":"Phanstiel S. Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T21:46:18.000Z","date":"2026-02-25","kind":"purchase","planned":false,"acquired":true,"shares":6100,"price":4.736,"value":28889.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.725 to $4.75, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":183544,"source":{"system":"sec-edgar","filing":"0001471518-26-000002","document":"wk-form4_1772228775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000147151826000002/wk-form4_1772228775.xml","form_type":"4"}},{"id":922973,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T22:30:14.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":4994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026."}],"balance_after":97624,"source":{"system":"sec-edgar","filing":"0002082246-26-000002","document":"wk-form4_1770157811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224626000002/wk-form4_1770157811.xml","form_type":"4"}},{"id":922972,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-03T22:30:09.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":32810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026."}],"balance_after":414636,"source":{"system":"sec-edgar","filing":"0001517026-26-000002","document":"wk-form4_1770157806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000002/wk-form4_1770157806.xml","form_type":"4"}},{"id":922971,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-03T22:30:03.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":23697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026."}],"balance_after":193878,"source":{"system":"sec-edgar","filing":"0001922964-26-000004","document":"wk-form4_1770157800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000004/wk-form4_1770157800.xml","form_type":"4"}},{"id":922970,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-03T22:29:58.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":23697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026."}],"balance_after":202332,"source":{"system":"sec-edgar","filing":"0001843872-26-000003","document":"wk-form4_1770157795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184387226000003/wk-form4_1770157795.xml","form_type":"4"}},{"id":955762,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-02T21:17:40.000Z","date":"2026-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":418,"price":6.15,"value":2570.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 31, 2025."}],"balance_after":170181,"source":{"system":"sec-edgar","filing":"0001922964-26-000002","document":"wk-form4_1767388657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000002/wk-form4_1767388657.xml","form_type":"4"}},{"id":958993,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-29T21:30:28.000Z","date":"2025-12-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":21,"price":6.55,"value":137.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 24, 2025."}],"balance_after":92630,"source":{"system":"sec-edgar","filing":"0002082246-25-000008","document":"wk-form4_1767043825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224625000008/wk-form4_1767043825.xml","form_type":"4"}},{"id":971918,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39036,"kind":"person","name":"Raha Samraat S.","position":1,"cik":"0001738340","reported_name":"Raha Samraat S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-12T21:47:14.000Z","date":"2025-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":29634,"price":7.3,"value":216328.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 11, 2025."}],"balance_after":453104,"source":{"system":"sec-edgar","filing":"0001738340-25-000009","document":"wk-form4_1765576030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000173834025000009/wk-form4_1765576030.xml","form_type":"4"}},{"id":1035128,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-22T20:16:22.000Z","date":"2025-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1085,"price":7.77,"value":8430.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025."}],"balance_after":381826,"source":{"system":"sec-edgar","filing":"0001517026-25-000008","document":"wk-form4_1758572179.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702625000008/wk-form4_1758572179.xml","form_type":"4"}},{"id":1035127,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":74010,"kind":"person","name":"Munk Natalie","position":1,"cik":"0001932320","reported_name":"Munk Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-09-22T20:15:13.000Z","date":"2025-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":962,"price":7.77,"value":7474.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025."}],"balance_after":45167,"source":{"system":"sec-edgar","filing":"0001932320-25-000006","document":"wk-form4_1758572110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000193232025000006/wk-form4_1758572110.xml","form_type":"4"}},{"id":1035126,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-22T20:14:37.000Z","date":"2025-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":2559,"price":7.77,"value":19883.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025."}],"balance_after":92651,"source":{"system":"sec-edgar","filing":"0002082246-25-000006","document":"wk-form4_1758572074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224625000006/wk-form4_1758572074.xml","form_type":"4"}},{"id":1035125,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Strategy & Transformation"}}],"security":"Common Stock","published_at":"2025-09-22T20:14:04.000Z","date":"2025-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":958,"price":7.77,"value":7443.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025."}],"balance_after":127726,"source":{"system":"sec-edgar","filing":"0001843568-25-000006","document":"wk-form4_1758572042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000184356825000006/wk-form4_1758572042.xml","form_type":"4"}},{"id":1048700,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":60829,"kind":"person","name":"Fox Jennifer Lynne","position":1,"cik":"0001914879","reported_name":"Fox Jennifer Lynne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-04T20:14:17.000Z","date":"2025-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4435,"price":6.8,"value":30158.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 3, 2025."}],"balance_after":120481,"source":{"system":"sec-edgar","filing":"0001914879-25-000004","document":"wk-form4_1757016855.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000191487925000004/wk-form4_1757016855.xml","form_type":"4"}},{"id":1062943,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":23084,"kind":"person","name":"Wheeler Benjamin Richard","position":1,"cik":"0002082246","reported_name":"Wheeler Benjamin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-19T21:24:18.000Z","date":"2025-08-16","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":95210,"source":{"system":"sec-edgar","filing":"0002082246-25-000004","document":"wk-form4_1755638655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000208224625000004/wk-form4_1755638655.xml","form_type":"4"}},{"id":1120396,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41113,"kind":"person","name":"Dreismann Heinrich","position":1,"cik":"0001379372","reported_name":"Dreismann Heinrich","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:05:48.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":171444,"source":{"system":"sec-edgar","filing":"0001628280-25-029981","document":"wk-form4_1749240341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029981/wk-form4_1749240341.xml","form_type":"4"}},{"id":1120395,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":29725,"kind":"person","name":"Bisaro Paul","position":1,"cik":"0001237253","reported_name":"Bisaro Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:05:39.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":89941,"source":{"system":"sec-edgar","filing":"0001628280-25-029979","document":"wk-form4_1749240326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029979/wk-form4_1749240326.xml","form_type":"4"}},{"id":1120394,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38551,"kind":"person","name":"Davis Mark Steven","position":1,"cik":"0002024613","reported_name":"Davis Mark Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:05:23.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":24148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":46964,"source":{"system":"sec-edgar","filing":"0001628280-25-029977","document":"wk-form4_1749240308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029977/wk-form4_1749240308.xml","form_type":"4"}},{"id":1120393,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":22863,"kind":"person","name":"Phanstiel S. Louise","position":1,"cik":"0001471518","reported_name":"Phanstiel S. Louise","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:05:04.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":177444,"source":{"system":"sec-edgar","filing":"0001628280-25-029975","document":"wk-form4_1749240296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029975/wk-form4_1749240296.xml","form_type":"4"}},{"id":1120392,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39972,"kind":"person","name":"Newcomer Lee Nisley","position":1,"cik":"0001788981","reported_name":"Newcomer Lee Nisley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:04:52.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":132141,"source":{"system":"sec-edgar","filing":"0001628280-25-029974","document":"wk-form4_1749240285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029974/wk-form4_1749240285.xml","form_type":"4"}},{"id":1120390,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:04:42.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":92329,"source":{"system":"sec-edgar","filing":"0001628280-25-029973","document":"wk-form4_1749240274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029973/wk-form4_1749240274.xml","form_type":"4"}},{"id":1120391,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":40258,"kind":"person","name":"Kumar Rashmi","position":1,"cik":"0001824720","reported_name":"Kumar Rashmi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:04:31.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":127188,"source":{"system":"sec-edgar","filing":"0001628280-25-029972","document":"wk-form4_1749240262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029972/wk-form4_1749240262.xml","form_type":"4"}},{"id":1120389,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":11095,"kind":"person","name":"Skovronsky Daniel","position":1,"cik":"0001741474","reported_name":"Skovronsky Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:04:18.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":135806,"source":{"system":"sec-edgar","filing":"0001628280-25-029971","document":"wk-form4_1749240252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029971/wk-form4_1749240252.xml","form_type":"4"}},{"id":1128378,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39036,"kind":"person","name":"Raha Samraat S.","position":1,"cik":"0001738340","reported_name":"Raha Samraat S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-06-02T20:24:46.000Z","date":"2025-05-31","kind":"grant","planned":false,"acquired":true,"shares":1498,"price":3.562,"value":5335.876,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Myriad Genetics, Inc. Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":482738,"source":{"system":"sec-edgar","filing":"0001738340-25-000006","document":"wk-form4_1748895880.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000173834025000006/wk-form4_1748895880.xml","form_type":"4"}},{"id":1161751,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-05-02T20:15:16.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":236167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026."}],"balance_after":236167,"derivative":{"underlying":"Common Stock","underlying_shares":236167},"source":{"system":"sec-edgar","filing":"0002065630-25-000004","document":"wk-form4_1746216907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563025000004/wk-form4_1746216907.xml","form_type":"4"}},{"id":1161750,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2025-05-02T20:15:16.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":127629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":397534,"source":{"system":"sec-edgar","filing":"0002065630-25-000004","document":"wk-form4_1746216907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563025000004/wk-form4_1746216907.xml","form_type":"4"}},{"id":1161749,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39035,"kind":"person","name":"Donnelly Brian J","position":1,"cik":"0002065630","reported_name":"Donnelly Brian J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commerical Officer"}}],"security":"Common Stock","published_at":"2025-05-02T20:15:16.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":269905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":269905,"source":{"system":"sec-edgar","filing":"0002065630-25-000004","document":"wk-form4_1746216907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000206563025000004/wk-form4_1746216907.xml","form_type":"4"}},{"id":1162823,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-05-01T20:27:14.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":105785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026."}],"balance_after":105785,"derivative":{"underlying":"Common Stock","underlying_shares":105785},"source":{"system":"sec-edgar","filing":"0001517026-25-000005","document":"wk-form4_1746131228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702625000005/wk-form4_1746131228.xml","form_type":"4"}},{"id":1162816,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":39036,"kind":"person","name":"Raha Samraat S.","position":1,"cik":"0001738340","reported_name":"Raha Samraat S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-05-01T20:24:19.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":141050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026."}],"balance_after":141050,"derivative":{"underlying":"Common Stock","underlying_shares":141050},"source":{"system":"sec-edgar","filing":"0001738340-25-000003","document":"wk-form4_1746131053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000173834025000003/wk-form4_1746131053.xml","form_type":"4"}},{"id":1172162,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-04-15T20:14:36.000Z","date":"2025-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":942,"price":8.08,"value":7611.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2025."}],"balance_after":170599,"source":{"system":"sec-edgar","filing":"0001922964-25-000004","document":"wk-form4_1744748070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296425000004/wk-form4_1744748070.xml","form_type":"4"}},{"id":1172161,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-04-15T20:12:34.000Z","date":"2025-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1085,"price":8.08,"value":8766.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2025."}],"balance_after":382911,"source":{"system":"sec-edgar","filing":"0001517026-25-000002","document":"wk-form4_1744747947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702625000002/wk-form4_1744747947.xml","form_type":"4"}},{"id":1191624,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":74010,"kind":"person","name":"Munk Natalie","position":1,"cik":"0001932320","reported_name":"Munk Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-26T20:19:11.000Z","date":"2025-03-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":362,"price":9.73,"value":3522.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 25, 2025."}],"balance_after":46129,"source":{"system":"sec-edgar","filing":"0001932320-25-000002","document":"wk-form4_1743020344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000193232025000002/wk-form4_1743020344.xml","form_type":"4"}},{"id":1192732,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:25.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1904,"price":10.01,"value":19059.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":128684,"source":{"system":"sec-edgar","filing":"0001628280-25-014730","document":"wk-form4_1742933838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014730/wk-form4_1742933838.xml","form_type":"4"}},{"id":1192731,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":73648,"kind":"person","name":"Ancona Margaret","position":1,"cik":"0001843568","reported_name":"Ancona Margaret","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief of Staff"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:25.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":718,"price":10.01,"value":7187.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":130588,"source":{"system":"sec-edgar","filing":"0001628280-25-014730","document":"wk-form4_1742933838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014730/wk-form4_1742933838.xml","form_type":"4"}},{"id":1192730,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":74010,"kind":"person","name":"Munk Natalie","position":1,"cik":"0001932320","reported_name":"Munk Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:14.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":589,"price":9.98,"value":5878.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":46491,"source":{"system":"sec-edgar","filing":"0001628280-25-014728","document":"wk-form4_1742933827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014728/wk-form4_1742933827.xml","form_type":"4"}},{"id":1192729,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":74010,"kind":"person","name":"Munk Natalie","position":1,"cik":"0001932320","reported_name":"Munk Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:14.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":393,"price":9.98,"value":3922.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":47080,"source":{"system":"sec-edgar","filing":"0001628280-25-014728","document":"wk-form4_1742933827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014728/wk-form4_1742933827.xml","form_type":"4"}},{"id":1192728,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":74010,"kind":"person","name":"Munk Natalie","position":1,"cik":"0001932320","reported_name":"Munk Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:14.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1135,"price":10.01,"value":11361.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":47473,"source":{"system":"sec-edgar","filing":"0001628280-25-014728","document":"wk-form4_1742933827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014728/wk-form4_1742933827.xml","form_type":"4"}},{"id":1192727,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":74010,"kind":"person","name":"Munk Natalie","position":1,"cik":"0001932320","reported_name":"Munk Natalie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:14.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":428,"price":10.01,"value":4284.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":48608,"source":{"system":"sec-edgar","filing":"0001628280-25-014728","document":"wk-form4_1742933827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014728/wk-form4_1742933827.xml","form_type":"4"}},{"id":1192726,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:02.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1724,"price":9.98,"value":17205.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":178635,"source":{"system":"sec-edgar","filing":"0001628280-25-014727","document":"wk-form4_1742933813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014727/wk-form4_1742933813.xml","form_type":"4"}},{"id":1192725,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:02.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1177,"price":9.98,"value":11746.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":180359,"source":{"system":"sec-edgar","filing":"0001628280-25-014727","document":"wk-form4_1742933813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014727/wk-form4_1742933813.xml","form_type":"4"}},{"id":1192724,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:02.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":4493,"price":10.01,"value":44974.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":181536,"source":{"system":"sec-edgar","filing":"0001628280-25-014727","document":"wk-form4_1742933813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014727/wk-form4_1742933813.xml","form_type":"4"}},{"id":1192723,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52522,"kind":"person","name":"Haas Kevin Richard","position":1,"cik":"0001843872","reported_name":"Haas Kevin Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:17:02.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1694,"price":10.01,"value":16956.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":186029,"source":{"system":"sec-edgar","filing":"0001628280-25-014727","document":"wk-form4_1742933813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014727/wk-form4_1742933813.xml","form_type":"4"}},{"id":1192722,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:49.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":800,"price":9.98,"value":7984.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":171541,"source":{"system":"sec-edgar","filing":"0001628280-25-014726","document":"wk-form4_1742933802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014726/wk-form4_1742933802.xml","form_type":"4"}},{"id":1192721,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:49.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":545,"price":9.98,"value":5439.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":172341,"source":{"system":"sec-edgar","filing":"0001628280-25-014726","document":"wk-form4_1742933802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014726/wk-form4_1742933802.xml","form_type":"4"}},{"id":1192720,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:49.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":5334,"price":10.01,"value":53393.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":172886,"source":{"system":"sec-edgar","filing":"0001628280-25-014726","document":"wk-form4_1742933802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014726/wk-form4_1742933802.xml","form_type":"4"}},{"id":1192719,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:49.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2011,"price":10.01,"value":20130.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":178220,"source":{"system":"sec-edgar","filing":"0001628280-25-014726","document":"wk-form4_1742933802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014726/wk-form4_1742933802.xml","form_type":"4"}}],"next_cursor":"2025-03-25T20:16:49.000000Z,1192719"}